Why Mason

More Than You Imagine

Genetesis Expected to Land FDA Approval

Genetesis, a Mason based biotech company, and its CardioFlux technology is on the road to FDA approval with its recent ‘de novo’ request approval – opening the door for other innovative, novel medical devices and technology.

Read more from CincyInno here.